<VariationArchive VariationID="2837576" VariationName="NM_001164277.2(SLC37A4):c.1079del (p.Asn360fs)" VariationType="Deletion" Accession="VCV002837576" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-15" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2996133" VariationID="2837576">
      <GeneList>
        <Gene Symbol="SLC37A4" FullName="solute carrier family 37 member 4" GeneID="2542" HGNC_ID="HGNC:4061" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119024112" stop="119030877" display_start="119024112" display_stop="119030877" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_009646203.1" start="45712" stop="52476" display_start="45712" display_stop="52476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118895060" stop="118901615" display_start="118895060" display_stop="118901615" Strand="-" />
          </Location>
          <OMIM>602671</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164277.2(SLC37A4):c.1079del (p.Asn360fs)</Name>
      <CanonicalSPDI>NC_000011.10:119025234:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119025235" stop="119025235" display_start="119025235" display_stop="119025235" variantLength="1" positionVCF="119025234" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118895945" stop="118895945" display_start="118895945" display_stop="118895945" variantLength="1" positionVCF="118895944" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N360fs</ProteinChange>
      <ProteinChange>N382fs</ProteinChange>
      <ProteinChange>N287fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.119025236del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.119025236del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118895946del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118895946del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013331.1" sequenceAccession="NG_013331" sequenceVersion="1" change="g.10671del">
            <Expression>NG_013331.1:g.10671del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164277.2" sequenceAccession="NM_001164277" sequenceVersion="2" change="c.1079del" MANESelect="true">
            <Expression>NM_001164277.2:c.1079del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157749.1" sequenceAccession="NP_001157749" sequenceVersion="1" change="p.Asn360fs">
            <Expression>NP_001157749.1:p.Asn360fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164278.2" sequenceAccession="NM_001164278" sequenceVersion="2" change="c.1145del">
            <Expression>NM_001164278.2:c.1145del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157750.1" sequenceAccession="NP_001157750" sequenceVersion="1" change="p.Asn382fs">
            <Expression>NP_001157750.1:p.Asn382fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164279.2" sequenceAccession="NM_001164279" sequenceVersion="2" change="c.860del">
            <Expression>NM_001164279.2:c.860del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157751.1" sequenceAccession="NP_001157751" sequenceVersion="1" change="p.Asn287fs">
            <Expression>NP_001157751.1:p.Asn287fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164280.2" sequenceAccession="NM_001164280" sequenceVersion="2" change="c.1079del">
            <Expression>NM_001164280.2:c.1079del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157752.1" sequenceAccession="NP_001157752" sequenceVersion="1" change="p.Asn360fs">
            <Expression>NP_001157752.1:p.Asn360fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001467.6" sequenceAccession="NM_001467" sequenceVersion="6" change="c.1079del">
            <Expression>NM_001467.6:c.1079del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001458.1" sequenceAccession="NP_001458" sequenceVersion="1" change="p.Asn360fs">
            <Expression>NP_001458.1:p.Asn360fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_187" sequenceAccession="LRG_187">
            <Expression>LRG_187:g.10671del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_187t1" sequenceAccession="LRG_187t1">
            <Expression>LRG_187t1:c.1078del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_187p1" sequenceAccession="LRG_187p1" change="p.Asn360Thrfs">
            <Expression>LRG_187p1:p.Asn360Thrfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164277.2(SLC37A4):c.1079del (p.Asn360fs) AND Glucose-6-phosphate transport defect" Accession="RCV003618767" Version="1">
        <ClassifiedConditionList TraitSetID="1910">
          <ClassifiedCondition DB="MedGen" ID="C0268146">Glucose-6-phosphate transport defect</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10518030</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10923042</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12444104</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18835800</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32300528</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1910" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5201" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 1B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glucose-6-phosphate transport defect</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+1B/3121" DB="Genetic Alliance" />
                <XRef ID="30102006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD Ib</ElementValue>
                <XRef Type="MIM" ID="232220" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD1B</ElementValue>
                <XRef Type="MIM" ID="232220" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type I (GSDI) is characterized by accumulation of glycogen and fat in the liver and kidneys resulting in hepatomegaly and nephromegaly. Severely affected infants present in the neonatal period with severe hypoglycemia due to fasting intolerance. More commonly, untreated infants present at age three to four months with hepatomegaly, severe hypoglycemia with or without seizures, lactic acidosis, hyperuricemia, and hypertriglyceridemia. Affected children typically have doll-like faces with full cheeks, relatively thin extremities, short stature, and a protuberant abdomen. Xanthoma and diarrhea may be present. Impaired platelet function and development of reduced or dysfunctional von Willebrand factor can lead to a bleeding tendency with frequent epistaxis and menorrhagia in females. Individuals with untreated GSDIb are more likely to develop impaired neutrophil and monocyte function as well as chronic neutropenia resulting in recurrent bacterial infections, gingivitis, periodontitis, and genital and intestinal ulcers. Long-term complications of untreated GSDI include short stature, osteoporosis, delayed puberty, renal disease (including proximal and distal renal tubular acidosis, renal stones, and renal failure), gout, systemic hypertension, pulmonary hypertension, hepatic adenomas with potential for malignancy, pancreatitis, and polycystic ovaries. Seizures and cognitive impairment may occur in individuals with prolonged periods of hypoglycemia. Normal growth and puberty are expected in treated children. Most affected individuals live into adulthood.</Attribute>
                <XRef ID="NBK1312" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301489</ID>
                <ID Source="BookShelf">NBK1312</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">25356975</ID>
              </Citation>
              <XRef ID="364" DB="Orphanet" />
              <XRef ID="79259" DB="Orphanet" />
              <XRef ID="C0268146" DB="MedGen" />
              <XRef ID="MONDO:0009288" DB="MONDO" />
              <XRef Type="MIM" ID="232220" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8220078" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="18370459|MedGen:C0268146" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004432404" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10518030</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10923042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12444104</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18835800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32300528</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn360Thrfs*43) in the SLC37A4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 70 amino acid(s) of the SLC37A4 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. This variant disrupts a region of the SLC37A4 protein in which other variant(s) (p.Ala367Thr) have been determined to be pathogenic (PMID: 10518030, 10923042, 12444104, 18835800, 32300528). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC37A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.118895945del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268146" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8220078" TraitType="Disease" MappingType="XRef" MappingValue="C0268146" MappingRef="MedGen">
        <MedGen CUI="C0268146" Name="Glucose-6-phosphate transport defect" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

